Supplemental Table 1. Kaplan-Meier analyses to estimate median time to toxicity by lactate dehydrogenase levels and stage at diagnosis.

Name: Supplemental Table 1. Kaplan-Meier analyses to estimate median time to toxicity by lactate dehydrogenase levels and stage at diagnosis.
Creator: Catherina Pan
Published: 2023-07-28T14:58:09.509Z
Keywords: Cancer Stages, Melanoma, Lactate Dehydrogenase, Immune Checkpoint Inhibitor

Pan, Catherina; Lau, William; Kim, Daniel; Lau, Charles; Rowley, Rachael; Kanwar, Ruhi; LeBoeuf, Nicole; Nambudiri, Vinod

doi:10.17632/tpcwfk3tf3.1

Supplemental Table 1. Kaplan-Meier analyses to estimate median time to toxicity by lactate dehydrogenase levels and stage at diagnosis.

Published: 28 July 2023| Version 1 | DOI: 10.17632/tpcwfk3tf3.1

Contributors:

Catherina Pan, William Lau, Daniel Kim, Charles Lau, Rachael Rowley, Ruhi Kanwar, Nicole LeBoeuf, Vinod Nambudiri

Description

Supplemental data table for publication titled "Association between baseline lactate dehydrogenase and immune-related adverse events among patients with melanoma varies by tumor stage at immune checkpoint inhibitor initiation". The table illustrates the time to any organ system toxicity development by level of lactate dehydrogenase (elevated levels defined as 210 U/L by institutional standards), stratified by stage of melanoma tumor at time of immune checkpoint inhibitor therapy initiation.

Supplemental Table 1. Kaplan-Meier analyses to estimate median time to toxicity by lactate dehydrogenase levels and stage at diagnosis.

Description

Files

Categories

Licence